Literature DB >> 19474270

Validation of the SPF10 LiPA human papillomavirus typing assay using formalin-fixed paraffin-embedded cervical biopsy samples.

Barbara Dal Bello1, Arsenio Spinillo, Paola Alberizzi, Stefania Cesari, Barbara Gardella, Enrico Maria Silini.   

Abstract

Lower levels of performance of human papillomavirus (HPV) typing assays in studies using formalin-fixed paraffin-embedded (FFPE) tissue compared to those using exfoliated cervical cells have been reported. The interpretation of current studies is limited by bias in inclusion criteria, sample matching, and methods of cell collection. We aimed to validate FFPE tissue for typing by the use of the SPF(10) LiPA assay, comparing cervical scrapings to punch and cone biopsy specimens. We examined 165 paired cervical scraping and FFPE punch biopsy samples, and 66 paired FFPE punch and cone biopsy samples. HPV typing was performed using the SPF(10) LiPA assay. Kappa statistics were used to measure interrater agreement. The overall agreement with respect to HPV status was 100%. For 74.5% of subjects (kappa = 0.6147), the same numbers of HPV types were detected in scraping and biopsy specimens. The overall positive typing agreement was 95.4% (range, 93.4 to 97.3) for 441 out of 484 individual HPV type analyses. Agreement was good for HPV-39, -42, -43, and -70 (kappa = 0.6506 to 0.7166), excellent for HPV-6, -16, -18, -31, -33, -35, -40, -51, -52, -56, -58, and -66 (kappa = 0.8499 to 0.9665), and absolute for HPV-11, -44, -45, -53, and -68. In 43.9% of cases (kappa = 0.247), the same numbers of HPV types were found in punch and cone biopsy specimens. Overall positive agreement for typing was 86.8% (range, 82.5 to 91.1) for 204 out of 266 individual HPV type analyses. More infections by HPV-18, -33, -51, and -52 were detected in cone specimens. HPV typing by SPF(10) LiPA performed equally well for cervical scraping specimens and standard pathological material. Some viral types are preferentially detected in cone specimens, likely reflecting better sampling of diseased epithelium and endocervix tissue.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19474270      PMCID: PMC2708477          DOI: 10.1128/JCM.00286-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

Review 1.  Clinical utility of HPV genotyping.

Authors:  Chris J Meijer; Peter J Snijders; Philip E Castle
Journal:  Gynecol Oncol       Date:  2006-08-24       Impact factor: 5.482

2.  Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality.

Authors:  Melinda Butsch Kovacic; Philip E Castle; Rolando Herrero; Mark Schiffman; Mark E Sherman; Sholom Wacholder; Ana C Rodriguez; Martha L Hutchinson; M Concepción Bratti; Allan Hildesheim; Jorge Morales; Mario Alfaro; Robert D Burk
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

Review 3.  Immune responses to human papillomavirus.

Authors:  Margaret Stanley
Journal:  Vaccine       Date:  2006-03-30       Impact factor: 3.641

4.  Detection of persistent high risk human papillomavirus infections with hybrid capture II and SPF10/LiPA.

Authors:  Chris Perrons; Rosanne Jelley; Bernhard Kleter; Wim Quint; Nicola Brink
Journal:  J Clin Virol       Date:  2005-04       Impact factor: 3.168

5.  Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the roche linear array HPV genotyping test.

Authors:  Dennis van Hamont; Maaike A P C van Ham; Judith M J E Bakkers; Leon F A G Massuger; Willem J G Melchers
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

6.  Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR.

Authors:  Leen-Jan van Doorn; Anco Molijn; Bernhard Kleter; Wim Quint; Brigitte Colau
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

7.  Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities.

Authors:  Philip E Castle; Diane Solomon; Mark Schiffman; Cosette M Wheeler
Journal:  J Natl Cancer Inst       Date:  2005-07-20       Impact factor: 13.506

8.  Biases in human papillomavirus genotype prevalence assessment associated with commonly used consensus primers.

Authors:  Paul K S Chan; Tak-Hong Cheung; Ann O Y Tam; Keith W K Lo; So-Fan Yim; May M Y Yu; Ka-Fai To; Yick-Fu Wong; Jo L K Cheung; Denise P C Chan; Mamie Hui; Margaret Ip
Journal:  Int J Cancer       Date:  2006-01-01       Impact factor: 7.396

9.  Human papillomavirus (HPV) genotyping using paired exfoliated cervicovaginal cells and paraffin-embedded tissues to highlight difficulties in attributing HPV types to specific lesions.

Authors:  Patti E Gravitt; Leen Jan van Doorn; Wim Quint; Mark Schiffman; Allan Hildesheim; Andrew G Glass; Brenda B Rush; Jared Hellman; Mark E Sherman; Robert D Burk; Sophia S Wang
Journal:  J Clin Microbiol       Date:  2007-08-15       Impact factor: 5.948

10.  Comparison of the SPF10-LiPA system to the Hybrid Capture 2 Assay for detection of carcinogenic human papillomavirus genotypes among 5,683 young women in Guanacaste, Costa Rica.

Authors:  Mahboobeh Safaeian; Rolando Herrero; Allan Hildesheim; Wim Quint; Enrique Freer; Leen-Jan Van Doorn; Carolina Porras; Sandra Silva; Paula González; M Concepcion Bratti; Ana Cecilia Rodriguez; Philip Castle
Journal:  J Clin Microbiol       Date:  2007-03-07       Impact factor: 5.948

View more
  6 in total

1.  p16 positive oropharyngeal squamous cell carcinoma:an entity with a favorable prognosis regardless of tumor HPV status.

Authors:  James S Lewis; Wade L Thorstad; Rebecca D Chernock; Bruce H Haughey; James H Yip; Qin Zhang; Samir K El-Mofty
Journal:  Am J Surg Pathol       Date:  2010-08       Impact factor: 6.394

2.  Efficient DNA extraction for HPV genotyping in formalin-fixed, paraffin-embedded tissues.

Authors:  Martin Steinau; Sonya S Patel; Elizabeth R Unger
Journal:  J Mol Diagn       Date:  2011-05-14       Impact factor: 5.568

3.  Detection and significance of human papillomavirus, CDKN2A(p16) and CDKN1A(p21) expression in squamous cell carcinoma of the larynx.

Authors:  Rebecca D Chernock; Xiaowei Wang; Ge Gao; James S Lewis; Qin Zhang; Wade L Thorstad; Samir K El-Mofty
Journal:  Mod Pathol       Date:  2012-09-21       Impact factor: 7.842

4.  Comparison of human papillomavirus detection between freshly frozen tissue and paraffin embedded tissue of invasive cervical cancer.

Authors:  Michael Odida; Silvia de Sanjose; Sven Sandin; Beatriz Quiros; Laia Alemany; Belen Lloveras; Wim Quint; Bernhard Kleter; Maria Alejo; Leen-Jan van Doorn; Elisabete Weiderpass
Journal:  Infect Agent Cancer       Date:  2010-09-16       Impact factor: 2.965

5.  An overview of viral oncology in Italy - report from the Pavia meeting on solid tumors.

Authors:  Vittorio Perfetti; Mattia Ricotti; Franco Buonaguro; Umberto Tirelli; Paolo Pedrazzoli
Journal:  Infect Agent Cancer       Date:  2012-09-05       Impact factor: 2.965

6.  Detection of HPV DNA in paraffin-embedded cervical samples: a comparison of four genotyping methods.

Authors:  Felipe A Castro; Jill Koshiol; Wim Quint; Cosette M Wheeler; Maura L Gillison; Laurence M Vaughan; Bernhard Kleter; Leen-Jan van Doorn; Anil K Chaturvedi; Allan Hildesheim; Mark Schiffman; Sophia S Wang; Rosemary E Zuna; Joan L Walker; S Terence Dunn; Nicolas Wentzensen
Journal:  BMC Infect Dis       Date:  2015-11-25       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.